Pharmaceutical packaging, one of the most innovative sectors in Italy, plays a key role in ensuring product integrity, traceability and compliance with EU regulatory requirements. The ability to trace the path of a medicine along the entire distribution chain is essential to prevent counterfeiting, which not only harms manufacturers but also compromises patient safety. This mechanism is also indispensable for…
Centrality of the individual, sustainability and resilience. These are the pivotal points identified by the European Union for the development of Industry 5.0, a manufacturing paradigm more focused on the well-being of the individual, society and the Planet. The factory of the future, according to the EU's vision, will be increasingly smart. It will harness the potential offered by technological…
Innovation Impact - Effects, Impact and Future of Technological Innovation, the study conducted by Ipsos on behalf of the Rome Chamber of Commerce, was presented on October 13. Conducted on a sample of 4,000 people, in Italy, France, Germany and the United States, the research analysed the impact of new technologies in different areas through the participants' perceptions. According to…
In recent years, nutraceuticals have established themselves as a Made in Italy excellence, investing in the efficacy of active ingredients, the quality of raw materials, innovation and sustainability. Driving the growing interest of consumers in new forms of food, in addition to a greater attention to their own health and well-being, is the idea of ethical and sustainable consumption, capable…
Despite difficulties in supplies and the rising cost of raw materials, the Italian pharmaceutical industry still grew in 2022. Production was up 10 percent, with a total value of 38 billion euros and a 44 percent increase in exports. Signs that confirm the excellence of the Italian pharmaceutical supply chain, first in Europe with results that far exceed the main…
Innovation is a competitive advantage for European companies, which is essential to go along with the ecological transition, revitalise the economy, and ensure the well-being of citizens. The EU's anti-crisis strategies aim to strengthen autonomy in key high-innovation sectors such as pharma, which employed 840,000 people in 2021 and recorded a production value of €300 billion. "As well as driving…
Health and sustainability are closely related issues, involving environmental, economic and social aspects. Among the main challenges facing the Pharma and Healthcare sector today is undoubtedly the need to accelerate the green transition: a priority for institutional agendas, but also for new consumer groups, which are increasingly inclined to buy eco-friendly products. The EU's global strategy, in addition to reaffirming…
